- Oral presentation
- Published:
Magnetic resonance imaging of ductal carcinoma in situ
Breast Cancer Research volume 10, Article number: P8 (2008)
Intraductal cancer or ductal carcinoma in situ (DCIS) has been considered a mammographic disease. Before the advent of mammographic screening, only about 2% to 5% of breast cancers were diagnosed in the intraductal stage. Magnetic resonance imaging (MRI) has traditionally been considered insensitive for DCIS. More recent studies, however, suggest that, with appropriate diagnostic criteria, contrast-enhanced MRI may be a very sensitive tool for diagnosing DCIS, especially high-grade DCIS. In addition, MRI has been shown to be superior to delineate the intraductal extension of invasive cancers – another reason why preoperative staging with MRI is important. The likelihood with which the mammographic diagnosis of DCIS or DCIS components fails does not correlate with mammographic breast density – in other words, a missed mammographic diagnosis of DCIS is also conceivable in women with involuted breast. The present lecture summarizes the current level of evidence, and discusses the clinical implications of these findings.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuhl, C. Magnetic resonance imaging of ductal carcinoma in situ . Breast Cancer Res 10 (Suppl 3), P8 (2008). https://doi.org/10.1186/bcr2006
Published:
DOI: https://doi.org/10.1186/bcr2006